Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Exosomes can improve skin treatments with fewer side effects.

Immune activities and specific genes are important in male pattern baldness.

miR-155-5p can help diagnose and track alopecia areata severity.

DHEA may play a complex role in PCOS, affecting hormones, metabolism, and symptoms.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

Iron deficiency causes many symptoms, and transferrin saturation is a better diagnostic marker than hemoglobin.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

MicroRNAs and AI can improve cashmere goat hair quality and aid in hair disorder diagnosis.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Complete COVID-19 vaccination reduces the risk of long COVID.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

S100A6 is important for cell functions and can help diagnose and treat diseases.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Hair metal analysis may help diagnose Parkinson's disease and suggests gut involvement.

Changes in hair follicle structure may help diagnose and monitor alopecia.

AMH is a promising biomarker for diagnosing PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Early diagnosis and personalized treatment of PCOS improve quality of life and prevent complications.

Hair analysis could help diagnose and treat schizophrenia more effectively.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Exosomes show promise in dermatology but need more research and FDA approval for clinical use.